Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

AHP prepares new rapamycin derivatives

Feb. 14, 2000

New immunosuppressive agents derived from LK6-A

Feb. 14, 2000

ID Biomedical's GAS vaccine well tolerated in early clinical testing

Feb. 14, 2000

SmithKline Beecham and ImClone Systems to collaborate on meningitis vaccine

Feb. 11, 2000

Dynavax and Aventis Pasteur enter strategic collaboration to develop novel vaccines

Feb. 11, 2000

Immunomedics allowed patent for therapeutic vaccines

Feb. 10, 2000

FluMist provides unexpected protection against flu strain not covered by vaccine in children

Feb. 9, 2000

North American Vaccine reports Hib vaccine results to FDA advisory panel

Feb. 8, 2000

Development of Chlamydia vaccine subject of Argonex/Wyeth-Lederle collaboration

Feb. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...